OxyContin maker Purdue Pharma faces sentencing
OxyContin maker Purdue Pharma is expected to be ordered to pay $225 million in a criminal case related to how it sold its blockbuster opioid painkiller.
If a judge accepts the negotiated deal on Tuesday, it opens the door for a separate settlement of thousands of lawsuits over the toll of opioids to take effect.
Under that deal, the company would dissolve and members of the Sackler family who own the company would pay up to $7 billion over 15 years.
Some advocates want that deal blocked and are calling on members of the family to be criminally charged instead.
Purdue Pharma faces final sentencing
- OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves ABC News —
- OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves The Independent —
- OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves CTV News —
- OxyContin maker Purdue Pharma’s criminal sentence could be the last step before company dissolves Boston Globe —
- Purdue Pharma to pay more than $8bn to end US opioid case Financial Times —